Greenland Technologies Holding Corp.
GTEC Nasdaq General Industrial Machinery & Equipment Financials FY2018βFY2025
What Greenland Technologies Holding Corp. does
No business description yet.
- Legal name
- Greenland Technologies Holding Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 23, 2026
- Accession Β· CIK
- 0001213900-26-032928
0001735041
Revenue and margins
Greenland Technologies Holding Corp. had $90.7M of revenue in fiscal 2025, up 8.0% on the year before.
Net income and earnings per share
From fiscal 2018 to 2025, diluted EPS grew β12.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $15.1M in fiscal 2025, 16.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Greenland Technologies Holding Corp. returned $2.2M to shareholders in fiscal 2025, 15% of free cash flow. The diluted share count rose 18.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Greenland Technologies Holding Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $13.2M | $24.1M | $25.8M | $25.2M | $32.2M |
| Debt incl. finance leases | $9.0M | $9.5M | $3.0M | β | β |
| Net debt / EBITDA | β0.4x | β1.7x | β1.8x | β | β |
| Debt / equity | 0.1x | 0.1x | 0.1x | β | β |
| Interest coverage | 14.0x | 14.8x | 43.0x | 149.6x | 67.3x |
| Current ratio | 1.6x | 1.9x | 1.4x | 1.6x | 2.0x |
| Quick ratio | 1.3x | 1.6x | 1.0x | 1.2x | 1.5x |
| Total assets | $163M | $155M | $130M | $116M | $116M |
| Total liabilities | $87.7M | $75.7M | $79.8M | $62.3M | $49.5M |
| Shareholders' equity | $62.3M | $65.7M | $50.1M | $60.2M | $72.9M |
| Net debt (β = net cash) | β$4.2M | β$14.6M | β$22.8M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 8 | 5 / 9 | 5 / 9 | 5 / 9 | 5 / 9 | 5 / 8 | 6 / 8 |
| Accruals ratio | 3.2% | β3.2% | 3.4% | 8.2% | β4.1% | β12.8% | 0.6% | β9.2% |
| Altman Z'' | 0.53 | 3.20 | 3.01 | 3.93 | 4.42 | 3.05 | 4.66 | 5.70 |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $60.2M | $52.4M | $66.9M | $98.8M | $90.8M | $90.3M | $83.9M | $90.7M |
| Gross profit | $14.1M | $12.4M | $12.8M | $19.6M | $19.8M | $24.6M | $22.5M | $28.4M |
| Research and development | $2.5M | $2.4M | $2.4M | $5.5M | $5.8M | $5.4M | $2.9M | $3.9M |
| Operating income | $8.7M | $6.6M | $6.7M | $8.3M | $6.0M | $10.8M | $12.6M | $7.5M |
| Interest expense | $1.6M | $1.3M | $0.9M | $0.6M | $0.4M | $0.3M | $0.1M | $0.1M |
| Pretax income | $8.0M | $5.9M | $8.6M | $9.1M | $4.5M | β$23.3M | $16.7M | $12.1M |
| Income tax | $1.4M | $0.8M | $2.3M | $1.8M | $0.7M | $1.7M | $1.5M | $3.5M |
| Net income | $6.6M | $4.5M | $6.8M | $6.3M | $0.7M | β$15.9M | $14.1M | $4.9M |
| Net income to common | β | β | $6.4M | $7.3M | β | β | β | β |
| Diluted EPS | $0.79 | $0.56 | $0.67 | $0.58 | $0.06 | β$1.20 | $1.03 | $0.31 |
| Diluted shares | β | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||||
| Cash from operations | $3.1M | $8.0M | $2.7M | β$5.8M | $7.3M | $2.4M | $13.3M | $15.6M |
| Capital expenditure | $6.7M | $1.3M | β | β | β | $0.7M | $2.0M | $0.5M |
| Free cash flow | β$3.6M | $6.7M | β | β | β | $1.7M | $11.4M | $15.1M |
| Depreciation and amortization | $1.6M | $2.3M | $2.4M | $2.5M | $2.4M | $2.2M | $2.2M | $2.4M |
| Stock-based compensation | β | β | β | β | β | β | β | $5.5M |
| Dividends paid | β | $0.2M | β | β | β | $0.7M | $5.9M | $2.2M |
| Dividends and buybacks | β | $0.2M | β | β | β | $0.7M | $5.9M | $2.2M |
| Balance sheet | ||||||||
| Cash and short-term investments | $5.6M | $2.1M | $7.2M | $13.2M | $24.1M | $25.8M | $25.2M | $32.2M |
| Total debt | $28.2M | $20.9M | $19.5M | $9.0M | $9.5M | $3.0M | β | β |
| Current assets | $48.2M | $80.2M | $108M | $139M | $126M | $99.8M | $92.6M | $95.3M |
| Current liabilities | $63.2M | $56.0M | $78.8M | $85.5M | $66.2M | $72.5M | $57.5M | $48.3M |
| Inventory | $12.4M | $10.0M | $15.4M | $25.8M | $23.1M | $24.6M | $23.4M | $24.4M |
| Property and equipment, net | $22.1M | $20.6M | $20.1M | $19.0M | $15.6M | $13.7M | $13.1M | $11.9M |
| Goodwill | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β |
| Intangible assets | β | β | β | β | β | $0.2M | $0.1M | $0.1M |
| Total assets | $111M | $106M | $132M | $163M | $155M | $130M | $116M | $116M |
| Total liabilities | $79.7M | $59.5M | $81.3M | $87.7M | $75.7M | $79.8M | $62.3M | $49.5M |
| Shareholders' equity | $31.7M | $38.6M | $44.9M | $62.3M | $65.7M | $50.1M | $60.2M | $72.9M |
| Margins | ||||||||
| Gross margin | 23.4% | 23.6% | 19.2% | 19.8% | 21.8% | 27.2% | 26.8% | 31.4% |
| Operating margin | 14.4% | 12.6% | 10.0% | 8.3% | 6.6% | 11.9% | 15.0% | 8.3% |
| EBITDA margin | 17.1% | 17.0% | 13.7% | 10.9% | 9.2% | 14.4% | 17.7% | 10.9% |
| Net margin | 11.0% | 8.5% | 10.1% | 6.3% | 0.8% | β17.6% | 16.8% | 5.4% |
| FCF margin | β6.0% | 12.8% | β | β | β | 1.9% | 13.6% | 16.6% |
| Returns | ||||||||
| Return on capital | 13.2% | 9.9% | 8.6% | 11.3% | 9.9% | 31.2% | β | β |
| Return on capital employed | 18.0% | 13.1% | 12.6% | 10.7% | 6.7% | 18.6% | 21.7% | 11.1% |
| Return on equity | 20.9% | 12.7% | 16.2% | 11.7% | 1.2% | β27.4% | 25.5% | 7.4% |
| Return on assets | 5.9% | 4.1% | 5.7% | 4.3% | 0.5% | β11.1% | 11.4% | 4.3% |
| Return on tangible equity | 20.9% | 11.6% | 14.2% | 11.7% | 1.1% | β31.8% | 23.4% | 6.8% |
| Growth | ||||||||
| Revenue growth | β | β13.0% | 27.6% | 47.8% | β8.1% | β0.5% | β7.1% | 8.0% |
| Net income growth | β | β32.6% | 51.4% | β7.3% | β88.1% | β2,229.7% | β | β64.9% |
| EPS growth | β | β29.1% | 19.6% | β13.4% | β89.7% | β2,100.0% | β | β69.9% |
| FCF growth | β | β | β | β | β | β | 564.0% | 32.6% |
| Share count change | β | β | 26.5% | 8.0% | 9.7% | 11.3% | 2.8% | 18.8% |
| Financial health | ||||||||
| Net debt / EBITDA | 2.2x | 2.1x | 1.3x | β0.4x | β1.7x | β1.8x | β | β |
| Debt / equity | 0.9x | 0.5x | 0.4x | 0.1x | 0.1x | 0.1x | β | β |
| Interest coverage | 5.6x | 5.1x | 7.2x | 14.0x | 14.8x | 43.0x | 149.6x | 67.3x |
| Current ratio | 0.8x | 1.4x | 1.4x | 1.6x | 1.9x | 1.4x | 1.6x | 2.0x |
| Quick ratio | 0.6x | 1.3x | 1.2x | 1.3x | 1.6x | 1.0x | 1.2x | 1.5x |
| Capital allocation | ||||||||
| Capex / revenue | 11.1% | 2.5% | β | β | β | 0.8% | 2.3% | 0.6% |
| Stock comp / revenue | β | β | β | β | β | β | β | 6.1% |
| Payouts / FCF | β | 2.4% | β | β | β | 41.1% | 52.2% | 14.7% |
| Quality scores | ||||||||
| Piotroski F-score | β | 6.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 0.5 | 3.2 | 3.0 | 3.9 | 4.4 | 3.0 | 4.7 | 5.7 |
| Accruals ratio | 3.2% | β3.2% | 3.4% | 8.2% | β4.1% | β12.8% | 0.6% | β9.2% |
Source: SEC EDGAR XBRL filings (CIK 0001735041). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.